Page last updated: 2024-12-07
cellu-brite
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
cellu-brite: fluorescent whitening agent; optical brightener; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 6436869 |
| MeSH ID | M0056744 |
Synonyms (31)
| Synonym |
|---|
| einecs 205-117-2 |
| c.i. 40621 |
| benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis(5-((4,6-bis(phenylamino)-1,3,5-triazin-2-yl)amino)-, disodium salt |
| c.i. fluorescent brightener 9 |
| disodium 4,4'-bis((4,6-dianilino-1,3,5-triazin-2-yl)amino)stilbene-2,2'-disulphonate |
| cellu-brite |
| belophor od |
| 2,2'-stilbenedisulfonic acid, 4,4'-bis((4,6-dianilino-s-triazin-2-yl)amino)-, disodium salt |
| 4,4'-bis((4,6-dianilino-s-triazin-2-yl)amino)-2,2'-stilbenedisulfonic acid disodium salt |
| blankophor hzpa |
| disodium 4,4'-bis((4,6-dianilino-1,3,5-triazin-2-yl)amino)stilbene-2,2'-disulfonate |
| compound 19-28 |
| calcofluor white mr |
| ozp 9 [czech] |
| 4,4'-bis(4,6-dianilino-1,3,5-triazin-2-yl)aminostilbene-2,2'-disulfonate disodium salt |
| crn2143y31 , |
| ozp 9 |
| unii-crn2143y31 |
| benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis(5-((4,6-bis(phenylamino)-1,3,5-triazin-2-yl)amino)-, sodium salt (1:2) |
| ec 205-117-2 |
| disodium 4,4'-bis[(4,6-dianilino-1,3,5-triazin-2-yl)amino]stilbene-2,2'-disulphonate |
| W-109479 |
| ci 40621 |
| brightener ta |
| stralex dpa |
| tinopal tas |
| brightener br 36 |
| phorwite ba |
| disodium 4,4'-bis((2,4-dianilino-1,3,5-triazin-6-yl)amino)-2,2'-stilbenedisulfonate |
| fluorescent brightener 9 |
| Q27275700 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||